期刊文献+

老年冠心病患者阿司匹林抵抗的相关因素研究 被引量:7

Aspirin Resistance in the Elderly Patients with Coronary Artery Disease and Its Associated Clinical Factors
下载PDF
导出
摘要 目的了解老年冠心病患者阿司匹林抵抗(AR)的发生率,并对其相关危险因素进行分析。方法选择246例正规服用阿司匹林(100 mg/d)超过3个月的老年冠心病患者,以花生四烯酸(AA)和二磷酸腺苷(ADP)作为诱导剂测定其静脉血中的血小板聚集功能,按结果分为AR组、阿司匹林半抵抗(ASR)组和阿司匹林敏感(AS)组,分析与AR有关的危险因素。结果 AR的发生率为14.6%(36/246),ASR的发生率为31.3%(77/246),AS的发生率为54.1%(133/246)。与AS组相比,发生AR的老年冠心病患者患糖尿病比例增高,C反应蛋白(CRP)、总胆固醇(TC)、纤维蛋白原(Fb)水平明显升高,差异有统计学意义(P<0.05)。结论 AR的发生可能与伴发糖尿病、血浆CRP、TC、Fb水平升高有关。 Objective To investigate the morbidity rate of aspirin resistance (AR) and its risk factors in the elderly patients with coronary artery disease (CAD) . Methods A total of 246 elderly CAD patients took aspirin 100 mg/d over 3 months were recruited. The platelet aggregation induced by adenosine diphosphate (ADP) and arachidonic acid (AA) was used to evaluate AR. The patients were divided into AR group, aspirin semi -resistance (ASR) group and aspirin sensitive (AS) group. The difference in clinical characteristics among above three groups and independent risk factors associated with AR were analyzed. Results The incidence of AR, ASR and AS were 14. 6% (36/246), 31.3% (77/246) and 54. 1% ( 133/246 ), respectively. Compared with the AS group, the proportion of patients with diabetes, C -reactive protein (CRP), total choles- terol (TC), fibrinogen (Fb) concentrations were increased statistically significantly in the elderly patients with CAD of the AR groups (P 〈 0.05 ) . Conclusion AR is likely correlated with diabetes mellitas, increased plasma CRP, TC, and Fb concentration.
作者 曹益红
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第34期3873-3875,共3页 Chinese General Practice
关键词 冠状动脉疾病 阿司匹林抵抗 老年 影响因素 Coronary artery disease Aspirin resistance Aged Influencing factors
  • 相关文献

参考文献11

  • 1Patrono C,Coller B,FitzCerald CA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects the seventh ACCP confernce on antithrombotic and thrombolytic therapy[J].Chest,2004,126(3Supply):234S-264S.
  • 2Gum PA,Kottke MK,Poggio ED,et al.Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J].Am J Cardiol,2001,88(3):230-235.
  • 3Peter J,Mason MD,Alice K,et al.Aspirin resistance and atherothrombotic disease[J].Journal of the American College of Cardio,2005,46(6):986-993.
  • 4李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 5Fateh-Moghadam S,Plockinger U,Cabeza N,et al.Prevalence of aspirin resistance in patients with type 2 diabetes[J].Acta Diabetol,2005,42(2):99-103.
  • 6Weber AA,Zimmermann KC,Meyer-Kirchrath J,et al.Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance[J].Lancet,1999,353:900-908.
  • 7Cabeza N,Li Z,Schulz C,et al.Surface expression of collagen receptor Fc receptor-gamma/ glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells[J].Diabetes,2004,53(8):2117-2121.
  • 8郑娟.阿司匹林对心脑血管疾病的预防[J].实用心脑肺血管病杂志,2010,18(5):675-677. 被引量:16
  • 9陈利巧,芦靖,魏国会,张芹.阿司匹林抗动脉粥样硬化作用及机制[J].河北医药,2009,31(19):2539-2540. 被引量:7
  • 10卞秋武,林海龙,张静,徐鹤,唐学杰,杨红梅,张双月,王庆胜,柳东田,刘晓媛.高血压患者阿司匹林抵抗[J].中华高血压杂志,2007,15(5):367-371. 被引量:12

二级参考文献60

  • 1顾晴,陈纪林,阮英茆.阿司匹林、氯吡格雷及合用对兔动脉粥样硬化病变进展的抑制作用[J].中国医学科学院学报,2005,27(1):87-91. 被引量:46
  • 2周畅,张晨,陈红兵,金丽英,杨学伟,郭云良.血小板膜糖蛋白Ia C_(807)T基因多态性与脑血管疾病易感性的关系研究[J].中国全科医学,2005,8(8):612-614. 被引量:1
  • 3Smit AJ,Lutgers HL.The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation.Curr Med Chem,2004,11:2767-2784.
  • 4Prasad K,Lee P.Suppression of oridative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin.J Cardiovasc Pharmacol Ther,2003,8:61-69.
  • 5Pamukcu B. A review of aspirin resistance, definition, possible mechanisms, detection with platelet function tests, and its clinical outcomes [J]. J Thromb Thrombolysis, 2007, 23 (3) : 213 -222.
  • 6Mosorjakova D, Paluch Z, Aluslk S. Aspirin resistance [J]. Bratisl Lek Listy, 2007, 108 (1): 7-13.
  • 7Gum PA, Kottke - Marchant K, Poggio ED, et al. Profileand prevalence of aspirin resistance inpatientswith cardiovascular disease [ J ].Am J Cardiol, 2001, 88:230 -235.
  • 8Ishida F, Furihata K, Ishida K, et al. The largest variant of platelet glyeoprotein Ⅰ b alpha has four tandem repeats of 13 amino acids in the macroglyoopeptide region and a genetic linkage with methionine 145 [J]. Blood, 1995, 86 (4): 1357-1360.
  • 9Simsek S, Bleeker PM, van der Schoot CE, et al. Associationof a variable number of tandem repeats (VNTR) in glycoprotein I b alpha and HPA2 alloantigens [J]. Thromb Haemosta, 1994, 72 (5): 757- 761.
  • 10Conejero GR, Lozano ML, Rivera J, et al. Polymorphisms of platelet membrane glycoprotein I bot associated with arterial thrombotic disease [J]. Blood, 1998, 92 (8): 2771-2776.

共引文献229

同被引文献69

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部